Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567551 · ClinicalTrials.gov registry record
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 126
- Enrollment target
NCT03567551: Completed study, sponsored by University of Alabama at Birmingham.
NCT03567551 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03567551 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This is a research study designed to help identify preeclampsia in pregnant women earlier, and possibly lead to better treatment for women preeclampsia.
Primary Outcome
The investigators plan to perform targeted testing for markers that the investigators predict based on their findings or based on available published evidence
Interventions
- OTHER Women w/ Preeclampsia w/o Visual Disturbances or Headache
- OTHER Women w/ Preeclampsia w/ Visual Disturbances or Headaches
- OTHER Women w/o Preeclampsia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2021-09-15 |
What the finished NCT03567551 record still lists
NCT03567551 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Women w/ Preeclampsia w/o Visual Disturbances or Headache is the first listed.
NCT03567551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03567551 about?
NCT03567551 is a clinical study titled "Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B". This is a research study designed to help identify preeclampsia in pregnant women earlier, and possibly lead to better treatment for women preeclampsia.
What is the current status of trial NCT03567551?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2017-05-15. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT03567551?
The interventions under investigation include: Women w/ Preeclampsia w/o Visual Disturbances or Headache (OTHER), Women w/ Preeclampsia w/ Visual Disturbances or Headaches (OTHER), Women w/o Preeclampsia (OTHER).
Who is sponsoring clinical trial NCT03567551?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI